Treatment of respiratory dyskinesia with olanzapine.
Gotto
J
J
Department of Neuro-Oncology, MD Anderson Cancer Center, University of Texas, Houston 77030, USA.
D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D018492:Dopamine Antagonists / Q000009:adverse effects*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019338:Polypharmacy; D012120:Respiration Disorders / Q000139:chemically induced*
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine